Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -256.45% | 37.48% | -9.16% | -6.02% | 30.03% |
| Total Depreciation and Amortization | 0.12% | -2.33% | -0.35% | 0.35% | -6.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,860.05% | -36.68% | 83.78% | -11.36% | -72.94% |
| Change in Net Operating Assets | 48.37% | -297.98% | -57.85% | 257.15% | -190.60% |
| Cash from Operations | 16.82% | 9.20% | -26.73% | 31.88% | -7.89% |
| Capital Expenditure | 200.00% | -- | -- | -- | 44.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 200.00% | -- | -- | -- | 44.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 10,711.85% | -73.30% |
| Repurchase of Common Stock | 59.15% | -86.84% | 25.49% | 29.17% | 23.40% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33,326.76% | -86.84% | -100.07% | 12,527.23% | -75.95% |
| Foreign Exchange rate Adjustments | 82.35% | -366.67% | 492.31% | 43.48% | -141.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.74% | 8.11% | -160.97% | 243.49% | -14.80% |